Sayo Horibe
Overview
Explore the profile of Sayo Horibe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sato J, Horibe S, Kawauchi S, Sasaki N, Hirata K, Rikitake Y
J Neurochem
. 2018 Jul;
147(4):495-513.
PMID: 29981530
In the central nervous system, astrocytes extend endfoot processes to ensheath synapses and microvessels. However, the mechanisms underlying this astrocytic process extension remain unclear. A limitation of the use of...
12.
Horibe S, Tanahashi T, Kawauchi S, Murakami Y, Rikitake Y
BMC Cancer
. 2018 Jan;
18(1):47.
PMID: 29306323
Background: Exosomes, small-membrane vesicles, are secreted by cells and include several types of proteins and nucleic acids. Exosomes transfer cellular information derived from donor cells and are involved in various...
13.
Yamana S, Tokiyama A, Fujita H, Terao Y, Horibe S, Sasaki N, et al.
Biochem Biophys Res Commun
. 2017 Jun;
490(2):169-175.
PMID: 28601637
We have reported that knockdown of Necl-4 decreases vascular endothelial growth factor (VEGF)-induced phosphorylation of extracellular signal-regulated kinase (ERK) without affecting phosphorylation of VEGF receptor 2 (VEGFR2) in sparsely cultured...
14.
Terao Y, Fujita H, Horibe S, Sato J, Minami S, Kobayashi M, et al.
Biochem Biophys Res Commun
. 2017 Mar;
486(3):811-816.
PMID: 28351617
N-glycosylation of proteins is important for protein folding and function. We have recently reported that FAM5C/BRINP3 contributes to the tumor necrosis factor-α-induced expression of leukocyte adhesion molecules in vascular endothelial...
15.
Kawauchi S, Nakamura T, Horibe S, Tanahashi T, Mizuno S, Hamaguchi T, et al.
Biopharm Drug Dispos
. 2016 Sep;
37(9):522-532.
PMID: 27666336
The liver and the small intestine are closely related in the processes of drug absorption, metabolism and excretion via the enterohepatic circulation. Small intestinal ulcers are a serious adverse effect...
16.
Horibe S, Tanahashi T, Kawauchi S, Mizuno S, Rikitake Y
Int J Med Sci
. 2016 Sep;
13(9):653-63.
PMID: 27647994
Recent advances in diagnostic technologies have revealed that nonsteroidal anti-inflammatory drugs (NSAIDs) can cause serious mucosal injury in the upper and lower gastrointestinal tract (including the small intestine). A drug...
17.
Horibe S, Matsuda A, Tanahashi T, Inoue J, Kawauchi S, Mizuno S, et al.
Life Sci
. 2015 Jan;
124:31-40.
PMID: 25625243
Aims: Cisplatin (CDDP) is a platinum-based drug that is widely used in cancer chemotherapy, but the development of resistance in tumor cells is a major weakness of these treatments. Several...
18.
Kawauchi S, Nakamura T, Yasui H, Nishikawa C, Miki I, Inoue J, et al.
Int J Med Sci
. 2014 Oct;
11(12):1208-17.
PMID: 25317066
Background: Non-steroidal anti-inflammatory drugs induce the serious side effect of small intestinal ulcerations (SIUs), but little information is available regarding the consequences to drug metabolism and absorption. Aim: We examined...
19.
Horibe S, Nagai J, Yumoto R, Tawa R, Takano M
J Pharm Sci
. 2011 Jan;
100(7):3010-7.
PMID: 21274848
Cisplatin or cis-diamminedichloroplatinum (II) (CDDP) is one of the most potent anticancer drugs, but the emergence of acquired resistance to CDDP is a major problem in clinical settings. The purpose...
20.
Takara K, Kitada N, Yoshikawa E, Yamamoto K, Horibe S, Sakaeda T, et al.
Cancer Lett
. 2009 Feb;
278(1):88-96.
PMID: 19201079
It is important to clarify the molecular characteristics of tumor cells showing multidrug resistance (MDR) and to identify the novel targets or biomarkers for chemotherapy. The aim of this study...